Status:
UNKNOWN
His Pacing Feasibility and Cardiac Electrical Activation
Lead Sponsor:
Aalborg University Hospital
Conditions:
Pacing-Induced Cardiomyopathy
AV Block
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study will examine the clinical feasibility of His pacing in patients with expected high demand for ventricular pacing and no established indication for cardiac resynchronization therapy. Seconda...
Detailed Description
After being informed about the study and potential risks, all eligible patients giving written consent will be included. The study is a clinical single-center interventional study. The patients (n = 2...
Eligibility Criteria
Inclusion
- Permanent pacemaker indication with expected high demand of right ventricular pacing (\>40%) and left ventricular ejection fraction \>40%.
Exclusion
- No class I indication for CRT pacemaker (HRS 2018 Pacing Guidelines)
- Hemodynamically unstable patients
- Severely reduced kidney function
- Former serious adverse reactions to contrast media
- Pregnant or lactating
- Severe psychiatric disorder which can compromise compliance with protocol
Key Trial Info
Start Date :
February 15 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2024
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT04739553
Start Date
February 15 2021
End Date
January 1 2024
Last Update
February 4 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.